3 Women-Led Biotech Companies Focusing on Epigenetic Therapy
Cognition Therapeutics Advancing Pipeline for Lead Candidate in Treatment of Neurodegenerative Disorders
EpiBone Breaking Boundaries, not Bones
Aetion’s Real World Evidence Platform Collaborates with FDA to Create Breakthroughs in Evaluating Covid-19
Enzyvant’s Rethymic to be the First FDtreatment for Pediatirc Congenital Athymia
LambdaVision Utilizing Bacteriorhodopsin to Bring Light To Sufferers of Age-Related Macular Degeneration and Retinitis Pigmentosa
SkinIO: Enabling Virtual Early Detection Powered by AI Image Skin Analysis
Health Sciences
View MoreAccording to the American Academy of Dermatology Association, one in five Americans will develop skin…
LambdaVision is a biotech company, that is designing and developing a protein-based artificial retina. This retina will utilize a light-activated protein, bacteriorhodopsin to restore function sight to those who are blind due to retinal degenerative diseases, including age-related macular degeneration (AMD) and retinitis pigmentosa (RP).
